Medizinische Universität Graz - Research portal
Pöttler Tina |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Hochfellner, D; Poettler, T; Schoerghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Aberer, F; Berti, F; Lucarelli, F; Valgimigli, F; Mader, J
Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial.
J Diabetes Sci Technol. 2025; 19322968251342598
Doi: 10.1177/19322968251342598
PubMed
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Kopanz, J; Lagerwaard, B; Beran, M; Veldwijk, J; Mader, JK; Pöttler, T; Tews, D; Grobbee, DE; Zuidgeest, MGP, , Trials@Home, consortium
What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?
Clin Transl Sci. 2024; 17(11): e70070
Doi: 10.1111/cts.70070
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schütz, A; Rami-Merhar, B; Schütz-Fuhrmann, I; Blauensteiner, N; Baumann, P; Pöttler, T; Mader, JK
Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes.
J Diabetes Sci Technol. 2024; 19322968241230106
Doi: 10.1177/19322968241230106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Secco, K; Baumann, PM; Pöttler, T; Aberer, F; Cigler, M; Elsayed, H; Harer, CM; Weitgasser, R; Schütz-Fuhrmann, I; Mader, JK
Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in Austria.
Sensors (Basel). 2024; 24(14):
Doi: 10.3390/s24144514
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ware, J; Wilinska, ME; Ruan, Y; Allen, JM; Boughton, CK; Hartnell, S; Bally, L; de, Beaufort, C; Besser, REJ; Campbell, FM; Draxlbauer, K; Elleri, D; Evans, ML; Fröhlich-Reiterer, E; Ghatak, A; Hofer, SE; Kapellen, TM; Leelarathna, L; Mader, JK; Mubita, WM; Narendran, P; Poettler, T; Rami-Merhar, B; Tauschmann, M; Randell, T; Thabit, H; Thankamony, A; Trevelyan, N; Hovorka, R
Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.
J Diabetes Sci Technol. 2024; 18(4):882-888
Doi: 10.1177/19322968221141924
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Aberer, F; Haberl, HC; Elsayed, H; Pöttler, T; Hochfellner, DA; Mader, JK
Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy.
Diabetes Obes Metab. 2024; 26(9):4111-4115
Doi: 10.1111/dom.15719
Web of Science
PubMed
FullText
FullText_MUG
2023
Full paper/article (Journal)
** Schneider-Utaka, AK; Hanes, S; Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Hayes, J; Wilinska, ME; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R; Hood, KK
Patient-reported outcomes for older adults on CamAPS FX closed loop system.
Diabet Med. 2023; 40(9):e15126
Doi: 10.1111/dme.15126
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Kastner, JR; Poettler, T; Kopanz, J; Hochfellner, DA; Romey, M; Baumann, PM; Muchmore, D; Strasma, PJ; Mader, JK
Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies.
Diabetes Obes Metab. 2023; 25(4):1106-1111
Doi: 10.1111/dom.14935
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Scheikl, K; Pöttler, T; Harer, CM; Schmitt, LM; Mecani, R; Mader, JK; Treiber, G
Significant increase in diabetic ketoacidosis in adults with diabetes mellitus
WIEN KLIN WOCHENSCHR. 2023; 135: S779-S779.
[Poster]
Web of Science
Comment
** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK
Reply to Freckmann et al. Comment on "Hochfellner et al. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106".
Biosensors (Basel). 2023; 13(7): 710
Doi: 10.3390/bios13070710
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Full paper/article (Journal)
** Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Wilinska, ME; Hood, KK; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
LANCET HEALTH LONGEV. 2022; 3(3): E135-E142.
Doi: 10.1016/S2666-7568(22)00005-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK
Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study.
Biosensors (Basel). 2022; 12(2):
Doi: 10.3390/bios12020106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mader, JK; Aberer, F; Drechsler, KS; Pöttler, T; Lichtenegger, KM; Köle, W; Sendlhofer, G
Medication errors in type 2 diabetes from patients' perspective.
PLoS One. 2022; 17(4): e0267570
Doi: 10.1371/journal.pone.0267570
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Baumann, P; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK
Gender differences in within-day glycaemic variations in people with T1D. Insights from long-duration CGM data from a diabetes registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):231-232.
[Poster]
Web of Science
** Baumann, PM; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK
Patterns of sensor-detected hypoglycaemia in long-duration CGM data from a diabetes registry
DIABETOLOGIA. 2022; 65(SUPPL 1):S323-S323.
[Oral Communication]
Web of Science
** Boughton, C; Hartnell, S; Thabit, H; Mubita, W; Draxlbauer, K; Poettler, T; Wilinska, M; Hood, K; Mader, J; Narendran, P; Leelarathna, L; Evans, M; Hovorka, R
HYBRID CLOSED-LOOP GLUCOSE CONTROL COMPARED WITH SENSOR AUGMENTED PUMP THERAPY IN OLDER ADULTS WITH TYPE 1 DIABETES: A MULTICENTRE, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A54-A55.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN.
[Oral Communication]
Web of Science
** Cigler, M; Baumann, P; Elsayed, H; Hochfellner, D; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, J
Improved HbA1c is associated with better glycemic control in continuous glucose monitoring systems, but glycemic control is not influenced by treatment type or CGM duration
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):234-234.
[Poster]
Web of Science
** Hochfellner, DA; Baumann, P; Reinhard, A; Pottler, T; Roubik, L; Kogler, S; Cigler, M; Treiber, G; Mader, J
Switching from isCCGM without alarms to isCCGM with alarms: what is the benefit?
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):244-244.-ÖDG Jahrestagung 2022; NOV 17-19; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Kastner, J; Poettler, T; Kopanz, J; Hochfellner, D; Siegl, R; Romey, M; Muchmore, D; Strasma, P; Mader, J
CURRENT INSULIN INFUSION SET CRITERIA DO NOT REPRESENT REAL-LIFE SETTING AND MAY SKEW INFUSION SET FAILURE OUTCOMES IN EXTENDED-WEAR INFUSION SET STUDIES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A212-A212.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN.
[Poster]
Web of Science
** Mader, J; Tuca, A; Scholle, L; Pottler, T; Aberer, F; Reinhard, A; Herler, Y; Kopanz, J; Gamsey, S; Kamecke, U; Rebrin, K
The Lumee hydrogel optical glucose sensor in clinical evaluation for assessment of data processing in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):249-250.
[Oral Communication]
Web of Science
** Pottler, T; Kastner, J; Kopanz, J; Hochfellner, D; Romey, M; Muchmore, D; Strasma, P; Mader, J
Current insulin infusion set criteria do not represent real-life setting and may skew infusion set failure outcomes in extended wear infusion set studies
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):255-255.
[Oral Communication]
Web of Science
2021
Full paper/article (Journal)
** Boughton, CK; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, ME; Ashcroft, NL; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, JK; Evans, M; Leelarathna, L; Hovorka, R
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
Diabetes Obes Metab. 2021; 23(6):1389-1396
Doi: 10.1111/dom.14355
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fischer, LT; Hochfellner, DA; Knoll, L; Pöttler, T; Mader, JK; Aberer, F
Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
Cardiovasc Diabetol. 2021; 20(1): 89-89.
Doi: 10.1186/s12933-021-01283-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Simic, A; Schøndorff, PK; Stumpe, T; Heschel, M; Regittnig, W; Pöttler, T; Ninaus, D; Augustin, T; Groselj-Strele, A; Pieber, TR; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium
Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
Diabetes Obes Metab. 2021; 23(6):1402-1408
Doi: 10.1111/dom.14337
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Boughton, C; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, M; Ashcroft, N; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, J; Evans, M; Leelarathna, L
REDUCTION OF HYPOGLYCAEMIA USING HYBRID CLOSED-LOOP WITH FASTER-INSULIN ASPART COMPARED WITH STANDARD-INSULIN ASPART IN ADULTS WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. 2021; 23: A72-A73.
[Oral Communication]
Web of Science
** Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J
Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Cigler, M; Elsayed, H; Ziko, H; Hochfellner, D; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, JK
Shorter Diabetes Duration and Residual Beta Cell Function are associated with better glycemic Control as measured by continuous Glucose Monitoring in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):212-212.
[Oral Communication]
Web of Science
** Groselj-Strele, A; Elsayed, H; Cigler, M; Ziko, H; Hochfellner, DA; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Mader, JK
Influence of Seasons on glycemic Control as measured with CGM Metrics in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):219-219.
[Oral Communication]
Web of Science
** Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J
Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209.
[Poster]
Web of Science
** Mader, J; Simic, A; Roosen, M; Hartmann, M; Scholle, L; Siegl, R; Vardanyan, S; Pottler, T; Menzie, W; Gamsey, S; Rebrin, K; Kamecke, U
GLUCOSE TRACKING WITH OPTICAL MEASUREMENT IN CLINICAL EVALUATION-PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. 2021; 23: A37-A38.
[Oral Communication]
Web of Science
** Pottler, T; Etter, T; Kaestel, H; Schutz-Fuhrmann, I; Stechemesser, L; Dagenbach, N; Ebenbichler, C; Vonbank, A; Weitgasser, R; Mader, J
Comparison of Treatment Satisfaction with Pen-based Therapy versus the Accu-Chek (R) Solo and mylifeTM OmniPod (R) Insulin Pumps among pump-naive People with Type 1 Diabetes in Austria
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):225-226.
[Oral Communication]
Web of Science
** Secco, K; Ziko, H; Pottler, T; Hochfellner, D; Weitgasser, R; Schutz-Fuhrmann, I; Mader, JK
Glycemic control in type 1 diabetes during COVID-19 pandemic
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):220-220.
[Keynote lecture]
Web of Science
** Simic, A; Taucher, M; Hochfellner, D; Pottler, T; Aberer, F; Mader, J
Glucomen Day (R) CGM system accuracy assessment in individuals with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-200.
[Poster]
Web of Science
2020
Full paper/article (Journal)
** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Pöttler, T; Mueller, A; Eckstein, ML; Sourij, H; Mader, JK, , Hypo-RESOLVE, Consortium
People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study.
Diabet Med. 2020; 37(12):2153-2159
Doi: 10.1111/dme.14362
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Aberer, F; Hochfellner, D; Ziko, H; Sagmeister, MH; Cigler, M; Simic, A; Pottler, T; Sendlhofer, G; Beck, P; Mader, JK
Efficiency and Safety of an electronic Decision Support System for Insulin Therapy in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S334-S334.
[Poster]
Web of Science
** Cigler, M; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK; Moser, O
People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to perform a glucose scan during hypoglycaemia: a prospective observational study.
DIABETOLOGIA. 2020; 63(SUPPL 1):S359-S359.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; virtuell.
[Poster]
Web of Science
** Eckstein, M; Ziko, H; Moser, O; Elsayed, H; Cigler, M; Hochfellner, D; Pottler, T; Mueller, A; Sourij, H; Mader, J
DISCREPANCY OF GLYCAEMIC RANGES IN REGARD TO CGM METRICS FOR CLINICAL CARE VERSUS GUIDANCE FOR GLYCAEMIC TARGETS WITHIN THE RECENT CONSENSUS ON TIR.
DIABETES TECHNOL THE. 2020; 22: A106-A106.
[Poster]
Web of Science
** Fischer, LT; Aberer, F; Hochfellner, D; Knoll, L; Pottler, T; Mader, JK
Prescribing Indications and metabolic Effects of PCSK9-Inhibitors in a tertiary Center - A retrospective Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S349-S349.-ÖDG ;
[Poster]
Web of Science
** Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ;
[Poster]
Web of Science
** Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Poster]
Web of Science
** Hochfellner, D; Schondorff, P; Stumpe, T; Heschel, M; Pottler, T; Elsayed, H; Simic, A; Bytyqi, K; Augustin, T; Lueger, A; Mader, J
COMPARISON OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED ARTIFICIALLY CLOGGED LANTERN CATHETER VS. STANDARD INFUSION SET IN TYPE 1 DIABETES UNDER REAL-LIFE CONDITIONS.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A240-A241.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN.
[Poster]
Web of Science
** Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pottler, T; Treiber, G; Simic, A; Aberer, F; Mader, J
Scan-Behavior in People with Type-1-Diabetes and Flash-Glucose-Monitoring in a Real-World-Setting.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):76-76.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Onlinepräsentation]
Web of Science
** Hochfellner, DA; Ziko, H; Sagmeister, MH; Elsayed, H; Cigler, M; Poettler, T; Aberer, F; Sendlhofer, G; Beck, P; Mader, JK
Electronic Decision Support for Insulin Therapy Is Safe and Efficient in Inpatients with Type 2 Diabetes.
DIABETES. 2020; 69(S 1):-80th Scientific Sessions American Diabetes Association (ADA); JUN 12-16,2020; Chicago, IL, USA;.
Doi: 10.2337/db20-24-OR
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Moser, O; Ziko, H; Eckstein, M; Elsayed, H; Cigler, M; Hochfellner, D; Poettler, T; Mueller, A; Sourij, H; Mader, J
TIME IN RANGE (TIR) ACHIEVEMENT IN REGARD TO CLINICAL TARGETS IN PEOPLE WITH TYPE 1 DIABETES (PWT1D): A REAL WORLD SETTING.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A231-A231.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN.
[Poster]
Web of Science
** Moser, O; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, M; Sourij, H; Mader, JK
The FreeStyle Libre 1 isCGM System as the first objective Measuring Instrument for the Diagnosis of Hypoglycemia Unawareness in People with Type 1 Diabetes - A prospective Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S344.
[Poster]
Web of Science
** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Poettler, T; Mueller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK
People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia Have a Delayed Reaction to Perform a Glucose Scan during Hypoglycemia: A Prospective Observational Study.
DIABETES. 2020; 69: -80th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 12-16, 2020; ELECTR NETWORK.
Doi: 10.2337/db20-157-OR
[Onlinepräsentation]
Web of Science
FullText
FullText_MUG
** Simic, A; Ziko, H; Pottler, T; Hochfellner, D; Samonigg, J; Cigler, M; Beck, P; Aberer, F; Mader, JK
A retrospective assessment of blinded continuous glucose monitor accuracy during inpatient management of adults with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S363-S363.
[Poster]
Web of Science
Comment
** Eckstein, ML; Knoll, L; Pöttler, T; Hochfellner, DA; Müller, A; Sourij, H; Moser, O; Mader, JK
Interpreting the recent consensus on time in range for interstitial glucose right - Or wrong?
Diabetes Res Clin Pract. 2020; 162:108106
Doi: 10.1016/j.diabres.2020.108106
Web of Science
PubMed
FullText
FullText_MUG
2019
Abstract (Journal)
** Elsayed, H; Bytyqi, K; Simic, A; Cigler, M; Hochfellner, D; Ziko, H; Knoll, L; Pottler, T; Aberer, F; Mader, J
Influence of C-Peptide Status on Frequency and Mean Duration of Hypoglycemia, Time in Blood Sugar Target Range and HbA1c in Type 1 Diabetics using Flash Glucose Monitoring in clinical Routine
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471.
[Oral Communication]
Web of Science
** Hochfellner, DA; Ziko, H; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, J
Flash Glucose Monitoring in Routine Clinical Use in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470.
[Poster]
Web of Science
** Simic, A; Elsayed, H; Ziko, H; Hochfellner, D; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK
The effect of glucose scanning frequency on HbA1c in individuals with type 1 diabetes using FGM
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S482-S482.
[Keynote lecture]
Web of Science
** Ziko, H; Hochfellner, D; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK
Influence of Flash Glucose Monitoring on Glycemic Target Achievement
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S487-S487.
[Poster]
Web of Science
2018
Full paper/article (Journal)
** Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Johns, D; Trautmann, M; Warner, JL; Pieber, TR
Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.
Diabet Med. 2018; 35(10):1448-1456
Doi: 10.1111/dme.13708
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber; Mader, JK
Examination of a prolonged Wearing Period of the newly developed Insulin Infusion Lantern Catheter in Patients with Type 1 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360.
[Poster]
Web of Science
** Cigler, M; Pandis, M; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Augustin, T; Schwarzenbacher, D; Pieber, RT; Treiber, G; Mader, JK
ASSESSMENT OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED LANTERN CATHETER IN TYPE 1 DIABETES BY GLUCOSE CLAMP TECHNIQUE (A PILOT STUDY)
DIABETES TECHNOL THE. 2018; 20: A126-A127.
[Poster]
Web of Science
** Drechsler, K; Pottler, T; Elsayed, H; Kiesling, L; Aberer, F; Mader, J
A Questionnaire Survey on treatment-associated Errors from the Perspective of Patients with Type 2 Diabetes in an internistic Normal Ward
WIEN KLIN WOCHENSCHR. 2018; 130: 365-365.
[Poster]
Web of Science
** Kojzar, H; Frohlich-Reiterer, E; Mader, JK; Pottler, T; Elsayed, H; Jasser-Nitsche, H; Rami-Merhar, B; Fritsch, M; Nagl, K; Hofer, S; Abt, D; Binder, E; Streichen, E; Acerini, CL; de Beaufort, C; Campbell, F; Kapellen, T; Lawton, J; Roze, S; Sibayan, J; Sonesson, A; Allen, J; Tauschmann, M; Musolino, G; Barber, N; Wilinska, ME; Hovorka, R
Use of the artificial Pancreas in Infants with Diabetes mellitus Type 1 KidsAP01
WIEN KLIN WOCHENSCHR. 2018; 130: 347-348.
[Oral Communication]
Web of Science
** Mader, JK; Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G
Assessment of infusion set survival of the newly developed coated Lantern catheter in type 1 diabetes by glucose clamp technique
DIABETOLOGIA. 2018; 61: S395-S395.-54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 01-05, 2018; Berlin, GERMANY.
[Poster]
Web of Science
2017
Abstract (Journal)
** Pottler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK
Results of three Months of Insulin Therapy with PAQ((R)) in Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173.
[Poster]
Web of Science
2016
Abstract (Journal)
** Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
PAQ®, A Simple 3-Day Basal/Bolus Insulin Delivery Device for People with Type 2 Diabetes.
DIABETES TECHNOL THE. 2016; 18: A109-A109.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD) ; FEB 3-6, 2016; Milan, ITALY.
[Poster]
Web of Science
** Mader, JK; Lilly, LC; Aberer, F; Pottler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
Application of PAQ®, an Insulin Dosage Device for Patients with Type 2 Diabetes mellitus, for 3 Months
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S399-S400.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
2015
Abstract (Journal)
** Aberer, F; Lilly, LC; Pöttler, T; Becvar, S; Lanz, C; Novak, E; Trautmann, M; Pieber, TR; Mader, JK
Überprüfung der Effizienz und Sicherheit eines einfachen Insulinabgabegerätes (PaQ) bei Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S136-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Mader, JK; Lilly, L; Aberer, F; Poettler, T; Trautmann, M; Pieber, T
PAQ, A SIMPLE 3-DAY INSULIN DELIVERY DEVICE, IMPROVES GLYCEMIC CONTROL
DIABETES TECHNOL THE. 2015; 17: A13-A13.
[Oral Communication]
Web of Science